Cleared Traditional

K072618 - TWIN-PASS OTW CATHETER

K072618 is the FDA 510(k) clearance for TWIN-PASS OTW CATHETER by Vascular Solutions, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 65-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
65d
Days
Class 2
Risk

K072618 is an FDA 510(k) clearance for the TWIN-PASS OTW CATHETER, MODEL 5201. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vascular Solutions, Inc. (Minneapolis, US). The FDA issued a Cleared decision on November 21, 2007 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vascular Solutions, Inc. devices

Submission Details

510(k) Number K072618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2007
Decision Date November 21, 2007
Days to Decision 65 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 125d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 552
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K072618.
SCOUTPRO 8F, 7F AND SLITTER TOOL ADVANCED
K072329 · Biotronik, Inc. · Mar 2008
ACUITY UNIVERSAL CUTTER
K080154 · Cardiac Pacemakers, Inc. · Mar 2008
ADVANCE 18LP PTA DILATATION CATHETER
K073378 · Cook, Inc. · Dec 2007
PRECIOUS PLUS GUIDE CATHETER
K072316 · Asahi Intecc Co., Ltd. · Sep 2007
NEURON SUPPORT CATHETER SYSTEM, MODEL 5F/6F
K070970 · Penumbra, Inc. · Aug 2007
SCOUTPRO SLITTER TOOL ADVANCED, MODEL 356 552
K071665 · Biotronik, Inc. · Jul 2007